Amgen – Amgen Inc. stock outperforms competitors despite losses on the day
Shares of Amgen Inc.
slipped 0.86% to $238.68 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index
falling 1.31% to 4,166.45 and Dow Jones Industrial Average
falling 1.58% to 33,290.08. Amgen Inc. closed $38.01 below its 52-week high ($276.69), which the company achieved on January 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson
fell 1.96% to $161.98, Roche Holding AG Part. Cert.
fell 0.03% to $375.90, and Pfizer Inc.
fell 1.70% to $38.81. Trading volume (5.5 M) eclipsed its 50-day average volume of 2.6 M.